Endocannabinoid 2-arachidonoylglycerol protects neurons by limiting COX-2 elevation

被引:101
|
作者
Zhang, Jian [1 ]
Chen, Chu [1 ]
机构
[1] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Neurosci Ctr Excellence, New Orleans, LA 70112 USA
关键词
D O I
10.1074/jbc.M800524200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Endocannabinoids are involved in synaptic signaling and neuronal protection; however, our understanding of the mechanisms by which endocannabinoids protect neurons from harmful insults remains elusive. 2-Arachidonoylglycerol (2-AG), the most abundant endogenous cannabinoid and a full agonist for cannabinoid receptors (CB1 and CB2), is a substrate for cyclooxygenase-2 (COX-2) and can be metabolized by COX-2. Here we show, however, that 2-AG is also capable of suppressing elevation of hippocampal COX-2 expression in response to proinflammatory and excitotoxic stimuli. 2-AG prevents neurodegeneration from toxic assaults that elevate COX-2 expression and inhibits the COX-2 elevation-enhanced excitatory glutamatergic synaptic transmission. The action of 2-AG on suppression of COX-2 appeared to be mediated via the pertussis toxin-sensitive G protein-coupled CB1 receptor and MAPK/NF-kappa B signaling pathways. Our results reveal that 2-AG functions as an endogenous COX-2 inhibitor protecting neurons from harmful insults by preventing excessive expression of COX-2, which provides a mechanistic basis for opening up new therapeutic approaches for protecting neurons from inflammation-and excitotoxicity-induced neurodegeneration.
引用
收藏
页码:22601 / 22611
页数:11
相关论文
共 50 条
  • [41] Prelimbic Correlates of Fear Memory Generalization in Endocannabinoid 2-Arachidonoylglycerol Deficient States
    Rosas-Vidal, Luis
    Naskar, Saptarnab
    Altemuse, Megan
    Patel, Sachin
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 76 - 76
  • [42] Sleep Restriction Enhances the Daily Rhythm of Circulating Levels of Endocannabinoid 2-Arachidonoylglycerol
    Hanlon, Erin C.
    Tasali, Esra
    Leproult, Rachel
    Stuhr, Kara L.
    Doncheck, Elizabeth
    de Wit, Harriet
    Hillard, Cecilia J.
    Van Cauter, Eve
    SLEEP, 2016, 39 (03) : 653 - 664
  • [43] Role of the endocannabinoid 2-arachidonoylglycerol in aversive responses mediated by the dorsolateral periaqueductal grey
    Gobira, P. H.
    Almeida-Santos, A. F.
    Guimaraes, F. S.
    Moreira, F. A.
    Aguiar, D. C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 (01) : 15 - 22
  • [44] Endocannabinoid 2-Arachidonoylglycerol is Associated With Outcome After Aneurysmal Subarachnoid Hemorrhage.
    Ament, Zsuzsanna
    Hansen, Christina
    Wolcott, Zoe
    Patel, Aman
    Kimberly, W. Taylor
    STROKE, 2019, 50
  • [45] The endocannabinoid 2-arachidonoylglycerol (2-AG) is intravenously self-administered by nonhuman primates
    Justinova, Zuzana
    Redhi, Godfrey H.
    Goldberg, Steven R.
    FASEB JOURNAL, 2011, 25
  • [46] THE ENDOCANNABINOID 2-ARACHIDONOYLGLYCEROL (2-AG) INDUCES ENDOPLASMIC RETICULUM STRESS IN HUMAN CYTOTROPHOBLASTS
    Almada, Marta
    Pereira, Sara
    Fonseca, Bruno
    Midao, Luis
    Teixeira, Natercia
    Correia-da-Silva, Georgina
    PLACENTA, 2017, 57 : 299 - 300
  • [47] Prostaglandin E2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NFκB activity
    Hu, S. Shu-Jung
    Bradshaw, H. B.
    Chen, J. S-C
    Tan, B.
    Walker, J. Michael
    BRITISH JOURNAL OF PHARMACOLOGY, 2008, 153 (07) : 1538 - 1549
  • [48] 2-arachidonoylglycerol and the cannabinoid receptors
    Sugiura, T
    Waku, K
    CHEMISTRY AND PHYSICS OF LIPIDS, 2000, 108 (1-2) : 89 - 106
  • [49] The Endocannabinoid 2-Arachidonoylglycerol Bidirectionally Modulates Acute and Protracted Effects of Predator Odor Exposure
    Kondev, Veronika
    Morgan, Amanda
    Najeed, Mustafa
    Winters, Nathan D.
    Kingsley, Philip J.
    Marnett, Lawrence
    Patel, Sachin
    BIOLOGICAL PSYCHIATRY, 2022, 92 (09) : 739 - 749
  • [50] Increase in the circulating endocannabinoid 2-arachidonoylglycerol is associated with gabapentin use in septic ICU patients
    Raff, Hershel
    Kramer, David J.
    Hillard, Cecilia J.
    ENDOCRINE, 2017, 58 (01) : 203 - 204